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The Centers for Disease Control and Prevention (CDC) has collaborated 
with the government of Botswana since 1995 to strengthen tuberculosis (TB) 
control through public health research. In 2001 the partnership expanded to 
include HIV/AIDS programs. As an implementing agency of the U.S. President’s 
Emergency Plan for AIDS Relief (PEPFAR), CDC Botswana provides technical 
assistance and is currently conducting medical research that includes a pre-
exposure HIV prophylaxis adherence study, Gene Xpert evaluation, and the 
PEPFAR-funded Combination Prevention trial. 
HIV/AIDS 
Through PEPFAR, CDC Botswana provides technical assistance to help the ministry 
of health (MOH) implement an effective, efficient national HIV program. This 
support has contributed to saving the lives of men, women and children through 
high quality HIV treatment services and a comprehensive combination prevention 
strategy. Using a data-driven approach, this strategy is tailored to the unique 
characteristics of the local epidemic for maximum health impact. 
Key areas of focus include high quality prevention, care and treatment services; 
HIV/counseling and testing scale-up; TB/HIV integrated service delivery; blood 
safety; early infant diagnosis (EID); and strengthening health systems. Health 
system strengthening is needed for long term program sustainability and includes 
building country capacity in the areas of workforce development, epidemiology, 
surveillance, health information systems, and program monitoring and evaluation 
to assess impact and make rapid course corrections to keep pace with changes in 
the local epidemic. CDC also builds in-country capacity for skilled laboratory 
workers, and national laboratory services which are vital to the expansion of HIV 
treatment, diagnosis, and care.  
CDC support has played a key role in a number of Botswana success stories 
including its care and treatment program, the prevention of mother-to-child 
transmission (PMTCT), and voluntary medical male circumcision (VMMC). As of 
September 2012, 96% of men, women and children in need of HIV treatment 
received it. PMTCT has achieved a country-wide reduced transmission rate of less 
than 4%. The scale-up of VMMC has mounted to nearly 63,000 circumcisions 
conducted nationally over three years, with 65% of them achieved in 2012 alone. 
With CDC support, huge strides have also been made in building high quality 
laboratory systems and capacity. Recent accomplishments include the 
establishment of a national TB reference laboratory, the implementation of 
enhanced diagnostics, the deployment of a laboratory information system to 
support and improve lab management and quality assurance, and the achievement 




CDC office (physical 
presence) 
13 U.S. Assignees 
84 Locally Employed 
 
At a Glance  
Population: 2,139,900 
Per capita income: $17,460 
Life expectancy at birth 
women/men: 67/62 yrs 
Infant mortality rate: 
31/1000 live births 
Source: Population Reference Bureau Fact 
Sheet, 2014 
 
Top 10 Causes of Death 
1. HIV/AIDS 32% 
2. Malaria 7% 
3. TB 6% 
4. Diarrheal Diseases 4% 
5. Cancer 4% 
6. Pre-Term Birth 
Complications 2% 
7. Ischemic Heart Disease 2% 
8. Stroke 2% 
9. STDs 2% 
10. Road Injuries 2% 
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HIV Prevention Research 
In addition to PEPFAR funded programs, CDC collaborated on a study of 
the safety and efficacy of taking antiretroviral medication to prevent HIV 
infection. This clinical trial showed that a combination of antiretroviral 
medications reduced HIV spread among heterosexual adults in Botswana 
by nearly 70%. 
Health Systems Strengthening 
The Botswana MOH has expressed interest in building epidemiology 
capacity using the Field Epidemiology and Laboratory Training Program 
(FELTP). As strategizing and planning continue toward the development of 
a two-year FELTP, the MOH expressed an urgent need for FELTP-related 
short courses to address immediate needs within the health system. CDC 
has worked with the MOH and the University of Botswana to implement 
FELTP-related short courses for ten of their 24 district health management 
teams. The FELTP-related short course trainings are competency-based and 
focused on the participant’s current job duties and functions. The course is 
tailored to Botswana’s needs and promotes the country’s decentralized 
approach and builds capabilities at the district-level. These FELTP-related 
short courses encourage districts to review and analyze their own 
surveillance data at the local level to improve their response to outbreaks. 
Injury Prevention 
CDC’s Division of Unintentional Injury Prevention (DUIP) is currently 
working with the University of Botswana (UB) to build in-country capacity 
for injury prevention research by training and mentoring researchers. DUIP 
and UB are working on several projects together, including an economic 
analysis examining the costs of road traffic crash-related injuries and 
deaths in Botswana; the design of a road user knowledge, attitudes, and 
behaviors survey; and an evaluation of the effect of a 2008 national alcohol 
tax on alcohol-related road traffic crashes. 
Tuberculosis 
Botswana’s TB research program includes clinical trials, epidemiology and 
surveillance. Integration of the HIV and TB programs improved the quality, 
coverage, and impact of Botswana's TB and HIV national response. The 
program recently expanded to include treatment improvement, TB 
diagnosis and management, and TB transmission characteristics. 
 
 
Impact in Botswana 
 Groundbreaking CDC clinical trial 
of isoniazid prevention therapy 
(IPT) to prevent TB found: 
o Risk of TB disease in persons 
with positive TB skin test 
decreased 30-60% with six 
months treatment 
o 36 months was more effective 
than six to prevent TB disease 
o Botswana used results to 
design new IPT program and 
to form WHO guidelines for 
using TB skin tests and IPT in 
high HIV areas 
 More than 90% of HIV-infected 
pregnant Botswana women 
received antiretroviral 
prophylaxis 
 Mother-to-child HIV transmission 
was reduced to less than 4% 
 Botswana achieved over 95% 
coverage for antiretroviral 
therapy in eligible HIV-infected 
persons 
 
 
